A new technology in creating artificial pancreas that will independently control insulin levels in people with Type 1 diabetes took a leap forward in research from Medtronic Inc. (MDT) and Johnson & Johnson. The new scientific study is bringing hope into diabetics’s lives as they will now benefit from the artificial pancreas. The emerging artificial pancreas technology seeks to link a glucose monitor, or sensor, to a pump that delivers insulin on its own as needed, mimicking a healthy pancreas.
There is an estimated 5 percent of the 25.8 million Americans with diabetes have the Type 1 form, which is most often diagnosed in young people and requires lifelong management of the disease. Poor blood sugar control can led to complications including heart disease, nerve and kidney damage, blindness and amputations.
Diabetics suffer by having to continuously checking their blood sugar levels, so this new advancement can revolutionize treatment with this disease.
Picture by www.mendosa.com